CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Performance Stock Units | −15,478 | 15,476 | ||
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Grant or award · Performance Stock Units | +7,784 | 7,784 | ||
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Performance Stock Units | −3,893 | 3,891 | ||
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −7,648 | 15,296 | ||
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Grant or award · Performance Stock Units | +17,346 | 17,346 | ||
| 2022-03-02 | GOREVIC JASON N CHIEF EXECUTIVE OFFICER | Option exercise · Performance Stock Units | −5,782 | 11,564 | ||
| 2022-03-01 | Verstraete Stephany Chief Marketing Officer | Grant or award · Restricted Stock Units | +16,844 | 16,844 | ||
| 2022-03-01 | Vandervoort Adam C Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +22,571 | 22,571 | ||
| 2022-03-01 | Turitz Andrew SVP - Business Development | Grant or award · Restricted Stock Units | +16,170 | 16,170 | ||
| 2022-03-01 | Trencher Daniel SVP Corporate Strategy | Grant or award · Restricted Stock Units | +14,149 | 14,149 | ||
| 2022-03-01 | Napolitano Richard J Chief Accounting Officer | Grant or award · Restricted Stock Units | +4,043 | 4,043 | ||
| 2022-03-01 | Murthy Mala Chief Financial Officer | Grant or award · Restricted Stock Units | +40,426 | 40,426 | ||
| 2022-03-01 | Jensen Claus Torp Chief Innovation Officer | Grant or award · Restricted Stock Units | +33,688 | 33,688 | ||
| 2022-03-01 | Geshuri Arnnon Chief Human Resources Officer | Grant or award · Restricted Stock Units | +14,149 | 14,149 | ||
| 2022-03-01 | GOREVIC JASON N Chief Executive Officer | Grant or award · Restricted Stock Units | +67,376 | 67,376 | ||
| 2022-02-28 | Geshuri Arnnon Chief Human Resources Officer | Sale | −2,613 | $78.14 | $204K | 83,168 |
| 2022-02-27 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | Option exercise | +169,107 | 370,143 | ||
| 2022-02-18 | Jacobson Catherine Director | Option exercise | +734 | 1,468 | ||
| 2022-02-18 | Jacobson Catherine Director | Option exercise · Restricted Stock Units | −734 | 734 | ||
| 2022-02-02 | Napolitano Richard J Chief Accounting Officer | Sale | −824 | $78.66 | $65K | 1,195 |
Page 66 of 93 · 1,848 trades